In this video, Dr Robert P Giugliano explains how the results of the FOURIER-OLE trial will impact clinical practice and the important implications for patients. In addition, it includes a summary on how important the FOURIER-OLE results are for lipid management practice and how prescribers could view this data.

This video is part of a series of interviews, recorded at ESC Congress 2022 in Barcelona, in which Dr Michelle L O’Donoghue, Dr Marc S Sabatine and Dr Robert P Giugliano consider the importance and implications of the FOURIER-OLE trial.

Watch next:

FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

FOURIER-OLE: The Trial in Context

This programme is supported by an unrestricted educational grant from Amgen.